| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
|
Science
|
2005
|
39.06
|
|
2
|
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
|
Nature
|
2009
|
12.58
|
|
3
|
The mutational landscape of lethal castration-resistant prostate cancer.
|
Nature
|
2012
|
11.82
|
|
4
|
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
|
Nature
|
2007
|
10.94
|
|
5
|
Integrative molecular concept modeling of prostate cancer progression.
|
Nat Genet
|
2006
|
8.49
|
|
6
|
Autoantibody signatures in prostate cancer.
|
N Engl J Med
|
2005
|
7.56
|
|
7
|
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
|
Cell
|
2009
|
7.09
|
|
8
|
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
|
Cancer Cell
|
2005
|
6.04
|
|
9
|
Role of the TMPRSS2-ERG gene fusion in prostate cancer.
|
Neoplasia
|
2008
|
5.92
|
|
10
|
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.
|
Cancer Res
|
2004
|
5.88
|
|
11
|
EML4-ALK fusion lung cancer: a rare acquired event.
|
Neoplasia
|
2008
|
5.22
|
|
12
|
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
|
Cancer Res
|
2006
|
4.99
|
|
13
|
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer.
|
Cancer Cell
|
2007
|
4.43
|
|
14
|
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.
|
Cancer Res
|
2007
|
3.82
|
|
15
|
Antibody-based detection of ERG rearrangement-positive prostate cancer.
|
Neoplasia
|
2010
|
3.66
|
|
16
|
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.
|
Cancer Res
|
2008
|
3.59
|
|
17
|
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
|
Cancer Cell
|
2011
|
3.53
|
|
18
|
The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.
|
J Biol Chem
|
2007
|
3.38
|
|
19
|
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
|
Cancer Res
|
2008
|
3.35
|
|
20
|
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
|
Cancer Res
|
2008
|
2.87
|
|
21
|
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
|
Cancer Cell
|
2008
|
2.87
|
|
22
|
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.
|
Nat Med
|
2011
|
2.77
|
|
23
|
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.
|
Mod Pathol
|
2009
|
2.69
|
|
24
|
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
|
Clin Cancer Res
|
2009
|
2.51
|
|
25
|
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.
|
Neoplasia
|
2006
|
2.39
|
|
26
|
Integrative analysis of genomic aberrations associated with prostate cancer progression.
|
Cancer Res
|
2007
|
2.14
|
|
27
|
The evolving biology and treatment of prostate cancer.
|
J Clin Invest
|
2007
|
1.81
|
|
28
|
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
|
Prostate
|
2006
|
1.78
|
|
29
|
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.
|
Genome Res
|
2011
|
1.63
|
|
30
|
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
|
Cancer Res
|
2012
|
1.57
|
|
31
|
An in vivo mouse model for human prostate cancer metastasis.
|
Neoplasia
|
2008
|
1.54
|
|
32
|
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist.
|
Proc Natl Acad Sci U S A
|
2009
|
1.43
|
|
33
|
Whole transcriptome amplification for gene expression profiling and development of molecular archives.
|
Neoplasia
|
2006
|
1.41
|
|
34
|
CXCL5 promotes prostate cancer progression.
|
Neoplasia
|
2008
|
1.37
|
|
35
|
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.
|
Mol Cell
|
2012
|
1.34
|
|
36
|
Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.
|
Mod Pathol
|
2009
|
1.23
|
|
37
|
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.
|
Clin Cancer Res
|
2009
|
1.20
|
|
38
|
The role of sarcosine metabolism in prostate cancer progression.
|
Neoplasia
|
2013
|
1.18
|
|
39
|
Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer.
|
Prostate
|
2014
|
1.10
|
|
40
|
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
|
Neoplasia
|
2008
|
1.09
|
|
41
|
Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model.
|
Prostate
|
2013
|
1.06
|
|
42
|
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
|
Genome Biol
|
2014
|
1.04
|
|
43
|
CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.
|
PLoS One
|
2012
|
1.03
|
|
44
|
Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
|
Am J Clin Pathol
|
2006
|
1.01
|
|
45
|
Role of transcriptional corepressor CtBP1 in prostate cancer progression.
|
Neoplasia
|
2012
|
1.01
|
|
46
|
Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.
|
Cancer Res
|
2009
|
0.93
|
|
47
|
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
|
Am J Surg Pathol
|
2016
|
0.91
|
|
48
|
Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution.
|
Cancer J
|
2014
|
0.90
|
|
49
|
Integrating biomedical knowledge to model pathways of prostate cancer progression.
|
Cell Cycle
|
2007
|
0.90
|
|
50
|
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
|
Cancer Res
|
2010
|
0.90
|
|
51
|
Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.
|
Cancer
|
2013
|
0.87
|
|
52
|
E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes.
|
J Urol
|
2006
|
0.87
|
|
53
|
Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients.
|
Am J Surg Pathol
|
2014
|
0.85
|
|
54
|
Osteocytes serve as a progenitor cell of osteosarcoma.
|
J Cell Biochem
|
2014
|
0.83
|
|
55
|
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a rapid autopsy report of metastatic renal cell carcinoma.
|
Am J Surg Pathol
|
2014
|
0.83
|
|
56
|
Determination of 222RN level in groundwater using a Rad7 detector in the Bathinda district of Punjab, India.
|
Radiat Prot Dosimetry
|
2013
|
0.83
|
|
57
|
Uranium, radium and radon exhalation studies in geological samples belonging to some areas of punjab, using track etching technique.
|
J Environ Sci Eng
|
2005
|
0.83
|
|
58
|
Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.82
|
|
59
|
DEK expression in Merkel cell carcinoma and small cell carcinoma.
|
J Cutan Pathol
|
2012
|
0.82
|
|
60
|
Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.
|
Eur Urol
|
2010
|
0.81
|
|
61
|
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.
|
Am J Surg Pathol
|
2016
|
0.80
|
|
62
|
Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations.
|
Am J Surg Pathol
|
2015
|
0.78
|
|
63
|
Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification.
|
Arch Pathol Lab Med
|
2016
|
0.77
|
|
64
|
At the intersection of primary pulmonary myxoid sarcoma and pulmonary angiomatoid fibrous histiocytoma: observations from three new cases.
|
Histopathology
|
2014
|
0.77
|
|
65
|
The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells.
|
J Biol Chem
|
2012
|
0.77
|
|
66
|
Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
|
Horm Cancer
|
2015
|
0.77
|
|
67
|
Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
|
Am J Surg Pathol
|
2015
|
0.75
|
|
68
|
Immunohistochemical Characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in Cutaneous Leiomyomas for Detection of Familial Cancer Syndromes.
|
Am J Surg Pathol
|
2017
|
0.75
|
|
69
|
MiT Family Translocation-Associated Renal Cell Carcinoma: A Contemporary Update With Emphasis on Morphologic, Immunophenotypic, and Molecular Mimics.
|
Arch Pathol Lab Med
|
2015
|
0.75
|
|
70
|
Metastases to the kidney: a clinicopathological study of 43 cases with an emphasis on deceptive features.
|
Histopathology
|
2014
|
0.75
|
|
71
|
Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms.
|
Am J Surg Pathol
|
2016
|
0.75
|
|
72
|
Comprehensive Immunophenotypic Characterization of Adult and Fetal Testes, the Excretory Duct System, and Testicular and Epididymal Appendages.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.75
|
|
73
|
Analysis of uranium concentration in drinking water samples using ICPMS.
|
Health Phys
|
2013
|
0.75
|
|
74
|
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists.
|
Am J Surg Pathol
|
2015
|
0.75
|
|
75
|
Life time fatality risk assessment due to variation of indoor radon concentration in dwellings in western Haryana, India.
|
Appl Radiat Isot
|
2011
|
0.75
|
|
76
|
Integrative Clinical Genomics of Advanced Prostate Cancer.
|
Cell
|
2015
|
0.75
|
|
77
|
Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
|
Am J Surg Pathol
|
2014
|
0.75
|
|
78
|
Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.75
|
|
79
|
Study of seasonal variations for radon pollution in the environment of Muktsar and Ferozepur districts of Punjab using LR-115 plastic track detectors.
|
J Environ Sci Eng
|
2005
|
0.75
|
|
80
|
Assessment of radium and radon exhalation rate in soil and building material samples using LR-115 plastic track detectors.
|
J Environ Sci Eng
|
2013
|
0.75
|
|
81
|
Assessment of natural radioactivity levels and associated dose rates in soil samples from Northern Rajasthan, India.
|
Radiat Prot Dosimetry
|
2013
|
0.75
|
|
82
|
Comparative Study of Radon Concentration With Two Techniques and Elemental Analysis in Drinking Water Samples of the Jammu District, Jammu and Kashmir, India.
|
Health Phys
|
2017
|
0.75
|
|
83
|
Radon monitoring in groundwater samples from some areas of northern Rajasthan, India, using a RAD7 detector.
|
Radiat Prot Dosimetry
|
2012
|
0.75
|
|
84
|
Correction: The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
|
Oncotarget
|
2017
|
0.75
|
|
85
|
The diagnostic accuracy of percutaneous renal needle core biopsy and its potential impact on the clinical management of renal cortical neoplasms.
|
Arch Pathol Lab Med
|
2014
|
0.75
|
|
86
|
Utility of ERG Immunohistochemistry for Evaluation of Lymphovascular Invasion in Testicular Germ Cell Tumors: A Retrospective Pilot Study.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|